Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer

被引：1
|
作者：
van der Poel, Henk [1 ]
机构：
[1] Netherlands Canc Inst, Dept Urol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
来源：
EUROPEAN UROLOGY OPEN SCIENCE | 2021年 / 34卷
关键词：
EFFICACY;
D O I：
10.1016/j.euros.2021.08.011
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：68 / 69
页数：2
相关论文
共 18 条
  • [1] Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis
    Chow, Kit Mun
    So, Wei Zheng
    Lee, Han Jie
    Lee, Alvin
    Yap, Dominic Wei Ting
    Takwoingi, Yemisi
    Tay, Kae Jack
    Tuan, Jeffrey
    Thang, Sue Ping
    Lam, Winnie
    Yuen, John
    Lawrentschuk, Nathan
    Hofman, Michael S.
    Murphy, Declan G.
    Chen, Kenneth
    EUROPEAN UROLOGY, 2023, 84 (01) : 36 - 48
  • [2] 18F-prostate specific membrane antigen positron emission tomography/computerized tomography for lymph node staging in medium/high risk prostate cancer: A systematic review and meta-analysis
    Lv, Zhengtong
    Song, Liuqi
    Wang, Miao
    Hou, Huimin
    Li, Haodong
    Wang, Xuan
    Wang, Jianye
    Wang, Jianlong
    Liu, Ming
    CHINESE MEDICAL JOURNAL, 2024, 137 (08) : 949 - 958
  • [3] Long-Term Outcomes of Prostate-Specific Membrane Antigen-PET Imaging of Recurrent Prostate Cancer
    Kunst, Natalia
    Long, Jessica B.
    Westvold, Sarah
    Sprenkle, Preston C.
    Kim, Isaac Y.
    Saperstein, Lawrence
    Rabil, Maximilian
    Ghaffar, Umar
    Karnes, R. Jeffrey
    Ma, Xiaomei
    Gross, Cary P.
    Wang, Shi-Yi
    Leapman, Michael S.
    JAMA NETWORK OPEN, 2024, 7 (10) : e2440591
  • [4] Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer
    Yamamichi, Gaku
    Kato, Taigo
    Watabe, Tadashi
    Hatano, Koji
    Uemura, Motohide
    Nonomura, Norio
    ANTICANCER RESEARCH, 2024, 44 (03) : 879 - 888
  • [5] Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level
    Izumi, Kouji
    Lin, Wen-Jye
    Miyamoto, Hiroshi
    Huang, Chiung-Kuei
    Maolake, Aerken
    Kitagawa, Yasuhide
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (08) : 1413 - 1419
  • [6] Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
    Stuparu, Andreea D.
    Capri, Joseph R.
    Meyer, Catherine A. L.
    Le, Thuc M.
    Evans-Axelsson, Susan L.
    Current, Kyle
    Lennox, Mark
    Mona, Christine E.
    Fendler, Wolfgang P.
    Calais, Jeremie
    Eiber, Matthias
    Dahlbom, Magnus
    Czernin, Johannes
    Radu, Caius G.
    Lueckerath, Katharina
    Slavik, Roger
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (07) : 989 - 995
  • [7] Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard
    Stabile, Armando
    Pellegrino, Antony
    Mazzone, Elio
    Cannoletta, Donato
    de Angelis, Mario
    Barletta, Francesco
    Scuderi, Simone
    Cucchiara, Vito
    Gandaglia, Giorgio
    Raggi, Daniele
    Necchi, Andrea
    Karakiewicz, Pierre
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (01): : 1 - 17
  • [8] The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor
    Kuroda, Kenji
    Liu, He
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (04) : 1357 - 1366
  • [9] Gastrin-Releasing Peptide Receptor- and Prostate-Specific Membrane Antigen-Specific Ultrasmall Gold Nanoparticles for Characterization and Diagnosis of Prostate Carcinoma via Fluorescence Imaging
    Pretze, Marc
    Hien, Andreas
    Raedle, Matthias
    Schirrmacher, Ralf
    Waengler, Carmen
    Waengler, Bjorn
    BIOCONJUGATE CHEMISTRY, 2018, 29 (05) : 1525 - 1533
  • [10] Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent 90Y-DOTA-EB-MCG
    Wang, Zhantong
    Jacobson, Orit
    Tian, Rui
    Mease, Ronnie C.
    Kiesewetter, Dale O.
    Niu, Gang
    Pomper, Martin G.
    Chen, Xiaoyuan
    BIOCONJUGATE CHEMISTRY, 2018, 29 (07) : 2309 - 2315
12